Tonix Pharmaceuticals Holding (TNXP) Other Non-Current Assets (2010 - 2026)
Tonix Pharmaceuticals Holding's (TNXP) quarterly Other Non-Current Assets came in at $5000.0 in Q1 2026, down 99.44% year-on-year from $900000.0 in Q1 2025, and little changed quarter-over-quarter from $5000.0 in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $5000.0 for Q1 2026.
- On a quarterly basis, Other Non-Current Assets fell 99.44% year-over-year to $5000.0 in Q1 2026; TTM through Mar 2026 was $5000.0, a 99.44% decrease from a year earlier, with the FY2025 full-year figure at $5000.0, down 99.47% from the prior year.
- Other Non-Current Assets was little changed at $5000.0 in Q1 2026 per TNXP's latest filing, from $5000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.3 million in Q3 2025 and bottomed at $5000.0 in Q4 2025.
- The 5-year median for Other Non-Current Assets is $900000.0 (2025), against an average of $658941.2.
- Across the five-year window, Other Non-Current Assets jumped 327.65% in 2023 and slumped 99.47% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $264000.0 in 2022, then soared by 327.65% to $1.1 million in 2023, then declined by 15.77% to $951000.0 in 2024, then slumped by 99.47% to $5000.0 in 2025, then changed by 0.0% to $5000.0 in 2026.
- Per Business Quant, the three latest TNXP Other Non-Current Assets figures stand at $5000.0 (Q1 2026), $5000.0 (Q4 2025), and $1.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 60,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 104.24 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 14.48 Mn |
| 10 | Tonix Pharmaceuticals Holding | 142.07 Mn | 142.07 Mn | 5.30 Mn | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 931,000.00 |
| Mar 31, 2025 | 900,000.00 |
| Dec 31, 2024 | 951,000.00 |
| Sep 30, 2024 | 951,000.00 |
| Jun 30, 2024 | 961,000.00 |
| Mar 31, 2024 | 960,000.00 |
| Dec 31, 2023 | 1.13 Mn |
| Sep 30, 2023 | 1.05 Mn |
| Jun 30, 2023 | 292,000.00 |
| Mar 31, 2023 | 385,000.00 |
| Dec 31, 2022 | 264,000.00 |
| Sep 30, 2022 | 360,000.00 |
| Jun 30, 2022 | 379,000.00 |
| Mar 31, 2022 | 379,000.00 |
| Dec 31, 2021 | 379,000.00 |
| Sep 30, 2021 | 240,000.00 |
| Jun 30, 2021 | 240,000.00 |